Urban-rural differences in the quality of care for medicare patients with acute myocardial infarction.

BACKGROUND There are urban-rural differences in health care utilization in Kansas. This study was conducted to determine if similar differences exist in the quality of inpatient care provided for patients with acute myocardial infarction (AMI). METHODS All acute care hospitals in the state were stratified into 12 urban, 31 semirural, and 76 rural hospitals according to their location. Data from medical records of 2521 Medicare patients 65 years and older who had survived AMI and were discharged alive from hospitals during an 8-month period in 1994/1995 were abstracted. The measures of the quality of care (quality indicators [QIs]) were the use of aspirin (during hospital stay and at discharge) and the administration of beta-blockers, intravenous (IV) nitroglycerin, heparin, and reperfusion by thrombolytic therapy or primary angioplasty. RESULTS A significantly higher proportion of ideal candidates for the use of aspirin during hospital stay and at discharge, heparin, and IV nitroglycerin received these medications in urban hospitals, and a lower proportion of similar patients received these medications in rural hospitals compared with the patients in semirural hospitals (P<.001). Similar trends in each of the 6 QIs were observed for less than ideal patients (P<.05). Patient age was associated with a relatively poor quality of care in terms of the 6 QIs. Except for the administration of IV nitroglycerine to less than ideal patients, age adjustments did not change the observed urban-rural differences in the QI measures. CONCLUSION Relatively poor quality of care for patients with AMI was provided by rural hospitals where greater opportunity for improvement exists.

[1]  K Sheikh,et al.  The relation between volume and outcome in health care. , 1999, The New England journal of medicine.

[2]  A. Go,et al.  Outcome following acute myocardial infarction: are differences among physician specialties the result of quality of care or case mix? , 1999, Archives of internal medicine.

[3]  N. Powe,et al.  The association between hospital volume and survival after acute myocardial infarction in elderly patients. , 1999, The New England journal of medicine.

[4]  S. Gollub Is intensive drug therapy appropriate for older patients? , 1999, The Lancet.

[5]  J. Wennberg,et al.  Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project. , 1999, JAMA.

[6]  B. Gage,et al.  Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. , 1999, American heart journal.

[7]  Harlan M. Krumholz,et al.  Do “America's Best Hospitals” Perform Better for Acute Myocardial Infarction? , 1999 .

[8]  R. Califf,et al.  1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). , 1996, Journal of the American College of Cardiology.

[9]  C. Lewis,et al.  Rural epidemiology: insights from a rural population laboratory. , 1998, American journal of epidemiology.

[10]  H. Lawson,et al.  Mammography screening among California Medicare beneficiaries: 1993-1994. , 1998, American journal of preventive medicine.

[11]  H. Krumholz,et al.  National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. , 1998, JAMA.

[12]  K. Sheikh Defining and Achieving of Medical Care , 1998, American journal of medical quality : the official journal of the American College of Medical Quality.

[13]  K. Sheikh,et al.  URBAN-RURAL DIFFERENCES IN MEDICARE IN KANSAS , 1998 .

[14]  E. Huff,et al.  Comprehensive reliability assessment and comparison of quality indicators and their components. , 1997, Journal of clinical epidemiology.

[15]  J. Gurwitz,et al.  Coronary thrombolysis for the elderly. Is clinical practice really lagging behind evidence of benefit? , 1997, JAMA.

[16]  K. Merrell,et al.  Medicare beneficiaries covered by Medicaid buy-in agreements. , 1997, Health affairs.

[17]  Richard P. Lewis,et al.  ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction , 1996 .

[18]  P. Eggers,et al.  Effects of race and income on mortality and use of services among Medicare beneficiaries. , 1996, The New England journal of medicine.

[19]  W. O’Neill,et al.  Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.

[20]  W. O’Neill,et al.  Regional variation across the United States in the management of acute myocardial infarction. , 1995, The New England journal of medicine.

[21]  H. Krumholz,et al.  Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries. Patterns of use and outcomes. , 1995, Circulation.

[22]  D. Blazer,et al.  Health services access and use among older adults in North Carolina: urban vs rural residents. , 1995, American journal of public health.

[23]  B. McNeil,et al.  Variation in the use of cardiac procedures after acute myocardial infarction. , 1995, The New England journal of medicine.

[24]  L Pilote,et al.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1995, The New England journal of medicine.

[25]  H. Krumholz,et al.  Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project. , 1995, JAMA.

[26]  Jonathan P. Weiner,et al.  Variation in office-based quality , 1995 .

[27]  D Draper,et al.  Hospital characteristics and quality of care. , 1992, JAMA.

[28]  S. Jencks,et al.  The health care quality improvement initiative. A new approach to quality assurance in Medicare. , 1992, JAMA.

[29]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[30]  Bruce L. Miller,et al.  Office of Technology Assessment Task Force , 1991 .

[31]  D Draper,et al.  Predicting hospital-associated mortality for Medicare patients. A method for patients with stroke, pneumonia, acute myocardial infarction, and congestive heart failure. , 1988, JAMA.

[32]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[33]  J. L. Gall,et al.  APACHE II--a severity of disease classification system. , 1986, Critical care medicine.

[34]  R H Brook,et al.  Variations in the use of medical and surgical services by the Medicare population. , 1986, The New England journal of medicine.

[35]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[36]  A. McMillan,et al.  A Study of the “Crossover Population”: Aged Persons Entitled to Both Medicare and Medicaid , 1983, Health care financing review.